Campbell & Co Investment Adviser’s Veracyte VCYT Stock Holding History

Campbell & Co Investment Adviser’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-106,443	Closed	-$3.43M	–	1374
2026 Q1	$3.43M	Buy	106,443 +90,816	+581%	+$3.36M	0.2%	145
2025 Q4	$658K	Buy	+15,627	New	+$630K	0.03%	721
2025 Q3	–	Sell	-173,638	Closed	-$4.69M	–	1401
2025 Q2	$4.69M	Buy	173,638 +97,296	+127%	+$2.82M	0.3%	57
2025 Q1	$2.26M	Buy	+76,342	New	+$2.91M	0.17%	162
2024 Q3	–	Sell	-19,462	Closed	-$422K	–	1354
2024 Q2	$422K	Sell	19,462 -55,413	-74%	-$1.17M	0.04%	712
2024 Q1	$1.66M	Sell	74,875 -23,821	-24%	-$581K	0.14%	201
2023 Q4	$2.72M	Buy	+98,696	New	+$2.38M	0.24%	64
2023 Q1	–	Sell	-28,895	Closed	-$686K	–	1045
2022 Q4	$686K	Sell	28,895 -1,096	-4%	-$25.5K	0.16%	196
2022 Q3	$498K	Buy	+29,991	New	+$675K	0.11%	319
2021 Q3	–	Sell	-5,950	Closed	-$238K	–	786
2021 Q2	$238K	Buy	+5,950	New	+$254K	0.1%	397

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Campbell & Co Investment Adviser's VCYT Position: Q2 2026 in Review

Campbell & Co Investment Adviser sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 106,443 shares — an estimated $3.43M sold.

Campbell & Co Investment Adviser first reported a position in VCYT in Q2 2021 and held it in 10 quarters. The position peaked at $4.69M in Q2 2025. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

Campbell & Co Investment Adviser reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
Campbell & Co Investment Adviser sold 106,443 Veracyte shares in Q2 2026, an estimated $3.43M.
Campbell & Co Investment Adviser first reported a position in Veracyte in Q2 2021 and held it in 10 quarters.
Campbell & Co Investment Adviser's Veracyte position peaked at $4.69M in Q2 2025.
370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.